Dry eye therapeutic - EyeRx Research
Alternative Names: recombinant human lacritin - EyeRx ResearchLatest Information Update: 05 Sep 2023
At a glance
- Originator Eyerx Research
- Class Eye disorder therapies; Glycoproteins
- Mechanism of Action Glycoprotein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dry eyes
Most Recent Events
- 05 Sep 2023 Discontinued - Preclinical for Dry eyes in USA (Topical)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Dry-eyes in USA (Topical)
- 07 Jul 2016 Preclinical trials in Dry eyes in USA (Topical)